Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  fatigue
Country:  U.S.A.
Trial Type:  Supportive care
Trial Status:  Active
Results 1-25 of 73 for your search:
Start Over
Acupressure for Persistent Cancer Related Fatigue
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: CA151445, R01CA151445, NCT01281904
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000629591, GOG-0249, NCT00807768
Relaxation for Women With Breast Cancer Undergoing Radiotherapy
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2009-0976, NCI-2012-01895, 2T32CA009666-21, NCT01202851
Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MIND, P30CA021765, NCI-2012-02053, NCT01700959
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: A221101, N10C3, NCI-2012-02020, U10CA031946, NCT01781468
Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-12-08248, HM20003275, NCT02332928
Fatigue Reduction Diet
Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: HUM00075741, NCT01902745
Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors
Phase: Phase II
Type: Educational/Counseling/Training, Supportive care
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 06-08-010, NCT00646633
Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Germanium, NCT00651417
Multi-Media Imagery Program for Breast Cancer Patients (Phase II)
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MMR-117597, NCT01034215
Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: E2408, NCI-2011-02644, CDR0000683312, ECOG-E2408, NCT01216683
Ginseng on Cancer-Related Fatigue
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2009-0854, NCI-2011-01127, NCT01375114
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
Phase: Phase II
Type: Supportive care
Status: Active
Age: 6 to 19
Sponsor: NCI, Other
Protocol IDs: SCUSF 0901, ACCL0922, 5U10CA081920-11, NCT01381718
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: E1411, ECOG-E1411, NCI-2011-02980, CDR0000707057, NCT01415752
Multimodal Therapy for Treatment of Fatigue
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011-0389, RSG-11-170-01-PCSM, NCI-2011-02764, NCT01410942
Hippocampal-Avoiding Whole Brain Irradiation With Simultaneous Integrated Boost for Treatment of Brain Metastases
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: STU 042011-050, NCT01414738
Multimodal Therapy for Sleep Disturbances
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2012-0120, NCI-2012-01352, NCT01628029
Efficacy of Swedish Massage Therapy on Cancer-related Fatigue in Cancer Survivors
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: IRB00062853, R21AT007090, NCT01926678
Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer
Phase: Phase II
Type: Supportive care
Status: Active
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: 2013-0510, R01CA026582, NCI-2014-01979, NCT02055963
Administration of Jakafi (Ruxolitinib) for Symptom Control of Patients With Chronic Lymphocytic Leukemia (CLL): Phase II
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2013-0044, NCI-2014-01465, NCT02131584
Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 14-056, R01CA150226, NCT02137252
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: URCC13091, NCI-2014-01191, U10CA037420, UG1CA189961, R03CA175599, NCT02352779
Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 1408439554, NCT02410382
The Effect of Walking on Fatigue During Radiotherapy in Breast Cancer Patients 65 and Older
Phase: Phase II
Type: Supportive care
Status: Active
Age: 65 and over
Sponsor: Other
Protocol IDs: LCCC 1412, NCT02434367
Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 12D.396, NCT01878695
Start Over